SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028126
Filing Date
2018-11-07
Accepted
2018-11-07 17:16:31
Documents
51
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20180930.htm 10-Q 1709521
2 EX-31.1 cala-ex311_6.htm EX-31.1 15735
3 EX-32.1 cala-ex321_7.htm EX-32.1 7518
  Complete submission text file 0001564590-18-028126.txt   5869321

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cala-20180930.xml EX-101.INS 1392631
5 XBRL TAXONOMY EXTENSION SCHEMA cala-20180930.xsd EX-101.SCH 37443
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20180930_cal.xml EX-101.CAL 33539
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20180930_def.xml EX-101.DEF 106425
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20180930_lab.xml EX-101.LAB 277014
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20180930_pre.xml EX-101.PRE 213667
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 181167371
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1